Biogen Inc (NASDAQ: BIIB)

DRUGS - Biotechnology
Sector: Health Care

Stock price data as of 01/17/2020

Closing price: 285.50

Support price level:	$270.83
Resistance price level:	$302.25
Relative strength index (14-day RSI)	31.3
Beta	1.14

With a -15.6 percent return in the past year, this stock is among the worst 10 percent of performers in the S&P-100.
BIIB is one of this month's worst performers with a return of -3.7%, underperforming 90 percent of stocks in the S&P-100.
Down 3.7 percent, BIIB is one of this week's biggest decliners.
BIIB is one of this week's most volatile stocks in the S&P-100 with an estimated annualized standard deviation of 40.0%.
Volatility is forecast to fall over the next month.
BIIB is above its 200-day moving average, providing a measure of support for long positions.

Low	High	Price as % of Range
$216.71	$338.96	61.6%

200 day	50 day	20 day	10 day
$250.08	$293.85	$295.30	$292.20

(Annualized standard deviation)

Historical (5 year)	Last month	Current estimate	Next month forecast
37.2%	37.6%	40.0%	37.6%

There is an estimated 5% probability that the stock price of Biogen Inc will fall by more than: